Br J Haematol 2014 Oct;167(1):139-41

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate.

Eskazan AE1, Ayer M, Kantarcioglu B, Arica D, Demirel N, Aydin D, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T.
chronic myeloid leukaemia; efficacy; generic; imatinib mesylate
ukaemia; efficacy; generic; imatinib mesylate